baber/WOPTO huggingface dataset:
Patent CA-2522694-C (CA)
Title: Printed circuit device with integrated antenna and implantable sensor processing system with integrated printed circuit board antenna
Inventor: COLVIN JR ARTHUR E
IPC: H05K1/03
Filed: 2004-04-14
Granted: 2014-07-08
Abstract: A printed circuit device used in conjunction with inductive power and data transmission applications is formed substantially of ferrite material, with an inductive coil conductor formed around the substrate to increase the electromagnetic properties of the coil for both power and data transmission functions, thereby eliminating the need for a discrete ferrite core wire-wound coil to be connected to the circuit device.
Patent CA-2529268-C (CA)
Inventor: LEGORE AUDLEY
IPC: A61K31/185
Filed: 2004-06-21
Granted: 2013-10-29
Abstract: Therapeutic formulations and methods for inhibiting amyloid deposition in a subject, whatever its clinical setting, are described. Therapeutic formulations and methods for preventing or treating amyloidosis and/or amyloid-related disease are also described.
Patent CA-2530882-C (CA)
Inventor: VERRIER BERNARD
IPC: A61P11/00
Filed: 2004-06-29
Granted: 2012-11-20
Abstract: Nouvelle utilisation des n-alkanols comme activateurs du canal CFTR (cystic fibrosis transmembrane conductance regulator) et application de ladite utilisation aux traitements des pathologies dans lesquelles on observe un dysfonctionnement dudit canal, telles que la mucoviscidose.
Patent CA-2531542-C (CA)
Inventor: BARKER JOHN
IPC: E21B7/02
Filed: 2005-12-23
Granted: 2009-10-13
Abstract: This invention relates to a novel safety shield for rotary drilling rigs. More particularly, the invention pertains to a portable, clam-shell style extendible leg safety shield which can be readily installed on the ground around the drill stem of an operational drilling rig, such as an oil well drilling rig. A safety shield for use in association with rotary drilling rigs comprising (a) a first protective shield; (b) a second protective shield hinged to the first shield; (c) a first leg assembly connected to the exterior of the first shield; (d) a second leg assembly secured to the exterior of the second shield; and (e) a securing mechanism for securing the first shield to the second shield.
Patent CA-2533867-C (CA)
Inventor: SEYBOTH WILLIAM J
IPC: A61F2/16
Filed: 2004-08-19
Granted: 2009-05-19
Abstract: L'invention porte sur un injecteur d'implant intraoculaire préchargé comprenant un dispositif de retenue destiné à retenir de manière libérable un implant intraoculaire à l'état non tendu. Le dispositif de retenue et l'implant intraoculaire sont fixés amovibles au corps de l'injecteur et sont scellés dans le même conditionnement en vue d'être introduits par le chirurgien. Selon une autre forme d'exécution, le dispositif de retenue et l'implant intraoculaire sont couplés et scellés ensemble dans un conditionnement et le corps de l'injecteur est scellé dans un conditionnement séparé par le chirurgien qui fixe le dispositif de retenue au corps de l'injecteur au moment de l'opération. Pour introduire l'implant intraoculaire au moyen du corps de l'injecteur, le dispositif de retenue est retiré du corps de l'injecteur, dégagent ainsi l'implant intraoculaire du dispositif de retenue, et est placé à l'état non tendu dans le corps de l'injecteur. Un compresseur est mis en positon fermée pour comprimer l'implant intraoculaire, l'extrémité de l'injecteur est insérée dans une petite incision pratiquée dans l'oeil et un plongeur avance de façon à faire rentrer et sortie l'implant intraoculaire de l'extrémité du corps de l'injecteur et à l'introduire dans l'oeil.
Patent CA-2534402-C (CA)
Inventor: NIE SHUMING
IPC: G01N33/552
Filed: 2003-09-18
Granted: 2013-06-25
Abstract: Briefly described, embodiments of this disclosure include structures, methods of forming the structures, and methods of using the structures. One exemplary structure, among others, includes a nanospecies and a porous material. The nanospecies has a first characteristic and a second detectable characteristic.  In addition, a second detectable energy is produced corresponding to the second detectable characteristic upon exposure to a first energy. The porous material has the first characteristic and a plurality of pores. The first characteristic causes the nanospecies to interact with the porous material and become disposed in the pores of the porous material.
Patent CA-2536269-C (CA)
Title: Positive displacement sorter shoe
Inventor: VEIT FRANK W
IPC: B65G47/84
Filed: 2004-07-30
Granted: 2012-02-28
Abstract: A positive displacement sorter apparatus (10) and method includes providing a plurality of interconnected slats (20) defining an endless web, an upper run of the web defining a conveying surface (11). A plurality of pusher shoes (14) are provided, each moving along at least one of the plurality of slats to laterally displace articles on the conveying surface. Each of the pusher shoes includes a diverting portion (16) extending above the conveying surface. The diverting portion includes a diverting surface (18) and a stop surface (22).  The diverting surface contacts an article and laterally displaces that article. A lifting force is applied by the diverting surface to a portion of the article being diverted. The stop surface limits movement of the article relative to the pusher shoe.
Patent CA-2538723-C (CA)
Inventor: RIOUX ANDRE
IPC: H02G3/04
Filed: 2004-04-01
Granted: 2010-07-20
Abstract: A fitting for use in retaining a plurality of accessory members to a vertical modular structural unit of a telecommunications tower, electricity pylon or like structure. The unit has a plurality of vertical sides wherein each side has at least one side aperture. The fitting has a body; a body plate attached to the body and so-shaped as to be cooperable with a side of the unit and receivable in intimate engagement within the side aperture; attachments by which the fitting is attachable to the structure and the body plate is retained thereto receivable within the side aperture by retaining bolts; the body having at least one accessory, such as a guy rope, insulator, dish and platform-receiving aperture for retaining the accessory to the body. The shape of the apertures in each unit side which is complimentary with the body plate, provides a lighter, stronger and more efficacious modular unit and tower.
Patent CA-2540158-C (CA)
Title: Method for the preparation of 2-halo-2'-deoxyadenosine compounds from 2'-deoxyguanosine
Inventor: ROBINS MORRIS J
IPC: C07H19/167
Filed: 2003-09-25
Granted: 2011-07-05
Abstract: The present invention is a method for preparing 2-halo-6-aminopurines, and more specifically for preparing the clinical agent cladribine (2-chloro-2'-deoxyadenosine, C1dAdo, 4), a drug of choice against hairy-cell leukemia and other neoplasms, from 2-amino-6-~oxopurines, which are readily obtained from the naturally occurring compound 2'~deoxyguanosine. According to the methods of the present invention, the 6-oxo group of a protected 2'-deoxyguanosine (1) is converted to a 6-(substituted oxy) leaving group, or alternatively to a 6-chloro leaving group, the 2-amino group is replaced with a 2-chloro group, the 6-(substituted oxy) leaving group, or alternatively the 6-chloro leaving group, is replaced with a 6-amino group or, alternatively, a 2,6-dichloro substituted compound is selectively replaced group, and the protecting groups are removed.
Patent CA-2540650-C (CA)
Inventor: COUSTON MICHEL HENRI
IPC: F03B3/12
Filed: 2004-10-15
Granted: 2013-02-19
Abstract: The invention relates to a tip-forming element (10) comprising an axisymmetric surface (11a) which can be disposed in the extension of the wetted surface (31a) of the top (3) or the hub of a hydraulic machine wheel and which converges as it extends away from the wetted surface (31) in the direction of the axis of rotation (X - X') of the wheel (1) when the element is attached to the wheel (1). The inventive element (10) also comprises a second axisymmetric surface (13a) which is offset axially in relation to the first axisymmetric surface (11a) and which diverges as it extends away from the first convergent surface (11a).
Patent CA-2545076-C (CA)
Inventor: DAVIDSON MELANIE MILLICENT
IPC: A01N43/40
Filed: 2004-11-12
Granted: 2012-08-28
Abstract: L'invention concerne des procédés permettant de réguler les populations de thrips, au moyen d'agents répoussant et/ou attirant les thrips. Ces agents sont des dérivés de pyridine. Ladite invention a aussi trait à des procédés de prévention ou de minimisation des dégâts causés aux végétaux.
Patent CA-2545936-C (CA)
Title: Toy vehicle
Inventor: MOLL JOSEPH T
IPC: B65F9/00
Filed: 2004-09-22
Granted: 2010-08-17
Abstract: A toy vehicle (10) includes a housing (15); a chassis (20) having a rear end (24), a wing (150); a gear train cover (78), road wheels (54, 58) for running across support surface (S). The toy vehicle (10) further includes skid members (130,132), skid rails (144), a lift arm (62a) in retracted position with a second end (70), a strut (100).
Patent CA-2550448-C (CA)
Title: Applier for implantable medical device
Inventor: BYRUM RANDAL T
IPC: A61F2/02
Filed: 2006-06-20
Granted: 2016-01-19
Abstract: An attachment mechanism for a surgically implantable medical device includes one or more fasteners which may be simultaneously moved from an undeployed position to a deployed position by operation of an integral actuator. The attachment mechanism may be configured to be deactuated, and the fasteners simultaneously moved from a deployed position to an undeployed position, allowing removal or repositioning of the medical device. An applier includes a locator for detachably holding the implantable medical device, locating it at the desired position, and actuating the attachment mechanism. The applier is configured to undeploy the attachment mechanism the implantable medical device can be detached from the body tissue.
Patent CA-2551147-C (CA)
Title: Composition fongicide comportant un derive pyridylethylbenzamide et un compose apte a l'inhibition de germination de spores ou de croissance de mycelium en agissant sur diverses voies metaboliques
Inventor: GROSJEAN-COURNOYER MARIE-CLAIRE
IPC: A01N47/22
Filed: 2005-02-10
Granted: 2013-10-01
Abstract: La présente invention a trait à une composition comportant au moins un dérivé pyridyléthylbenzamide de formule générale (I) (a) et un composé apte à l'inhibition de germination de spores ou de croissance de mycélium en agissant sur diverses voies métaboliques (b) dans un rapport pondéral (a)/(b) entre 0,01 et 20. L'invention a également trait à une composition comportant en outre un composé fongicide additionnel. L'invention a trait en outre à un procédé pour la lutte préventive et curative contre des champignons phytopathogènes de cultures au moyen de cette composition.
Patent CA-2554884-C (CA)
Title: Metal-supporting photocatalyst and method for preparing the same
Inventor: CHENG SYH-YUH
IPC: B01J37/00
Filed: 2006-07-28
Granted: 2010-10-05
Abstract: A metal-supporting photocatalyst includes a metal deposit and nano-particles of a photocatalyst dispersed on the metal deposit. Preferably, the metal deposit is a metal electro-deposit. More preferably, the metal deposit has a dendritic structure. A method for preparing a metal-supporting photocatalyst, including forming a metal deposit of a supporting metal, and forming nano-particles of a photocatalyst on the metal deposit, is also disclosed.
Patent CA-2554926-C (CA)
Inventor: TANAKA NORIO
IPC: G02F1/31
Filed: 2005-03-14
Granted: 2014-02-11
Abstract: Data 12010, 12020, etc. to be sent to each of client devices 1201, 1203, etc.  from a data server device 1000 are, in a data communication unit 1100, first divided into electric signal packets by a data transmission/receipt control unit 1140, whereby an electric signal sequence tag is added to each electric signal packet, then converted into optical packets 12011, 12021, etc. by an optical signal transmitting unit 1120, and transmitted through an optical signal path 1110. At optical switch 1101, the optical paths of the packets are switched to optical signal paths 1111, 1112, etc. by the actions of optical destination tags 12111, 12121, etc. that are respectively synchronized with optical packets and irradiated by an optical signal transmitting unit 1120. At optical signal receiving units 1131, 1132, etc., the received optical packets are converted to electric signal packets, and reassembled to be original data 12010, 12020, etc. according to the identification information on the reassembly sequence recorded in the sequence tag in an electric signal packet by data transmission/receipt control units 1141, 1142, etc., and distributed to client devices 1201, 1202, etc. as electric signals.
Patent CA-2556489-C (CA)
Title: Use of folates for the prevention and treatment of vascular diseases
Inventor: ANTONIADES CHARALAMBOS
IPC: A61K31/616
Filed: 2006-08-21
Granted: 2011-06-14
Abstract: This invention relates to the use of folates for the prevention and/or treatment of cardiovascular diseases, such as atheroscle-rosis, and in particular for modulating endothelial nitric oxide synthase (eNOS). The invention further relates to pharmaceutical preparations consisting of said folates and a pharmaceutically acceptable carrier, optionally in combination with other pharma-ceutically active agents, as well as therapeutic methods using said folates or pharmaceutical preparations thereof.
Patent CA-2558600-C (CA)
Inventor: SAITOU ATSUSHI
IPC: A61K31/4184
Filed: 2005-03-10
Granted: 2013-07-09
Abstract: Novel amine compounds which are represented by the following formula (1) and efficacious against diseases such as a viral infectious disease with HIV, rheumatism, and cancer metastasis;  [Formula 1] (see formula 1) typically, A1 and A2 represent a hydrogen atom or a substitutable monocyclic or polycyclic heteroaromatic ring and W represents a substitutable benzene ring or any group represented by the following formula (10) or (11): [Formula 2] (see formula 10) [Formula 3] (see formula 11) where X represents O, CH2, C (=O) , NR11, or CHR35 and D represents a group represented by the following formula (6) : [Formula 4] (see formula 6) where Q represents a single bond, NR12, or a group represented by the formula (13) : [Formula 5] (see formula 13) and Y represents a group represented by the following formula (7): [Formula 6] (see formula 7) where Q represents a substitutable monocyclic or polycyclic aromatic ring; and B represents -NR25R26; and R1 to R26 in the above formulae represent a hydrogen atom, an alkyl group, an alkenyl group, or an alkynyl group.
Patent CA-2560233-C (CA)
Inventor: ROSENBERGER BERND
IPC: H01R13/24
Filed: 2005-03-21
Granted: 2012-09-04
Abstract: Disclosed is a coaxial plug-in connection, particularly for printed circuit boards (board-to-board connection), comprising an outer and an inner conductor (3, 4) that are assigned to each board (1 or 2) and can be electrically connected to the outer or inner conductor (3, 4) of the other respective board (2, 1) via an adapter which is provided in the form of a sleeve-shaped plug-in coupling (6) and encompasses a corresponding outer conductor piece (7) and inner conductor piece (10). The arrangement is designed in such a way that the inner conductor of the printed board (1, 2) is embodied as a spring metal sheet (4), one end of which is fixed to the board (1, 2) or an insulating element (5) while the other, free end (13) thereof can be made to engage with the inner conductor piece of the plug-in coupling (6), which is configured as a contact pin (10).
Patent CA-2564920-C (CA)
Inventor: BROWN MICHAEL S
IPC: H04M1/72436
Filed: 2005-02-25
Granted: 2011-04-12
Abstract: L'invention concerne de systèmes et des procédés permettant de traiter des messages électroniques. Un message électronique est examiné afin de savoir s'il contient une ou plusieurs propriétés de codage. Une indication visuelle est générée afin d'être utilisée dans un affichage à l'intention d'un utilisateur, cette indication visuelle est affichée jusqu'au point où la propriété de codage s'applique à une partie affichée du message.
Patent CA-2566802-C (CA)
Inventor: MARAKOVITS STEVE
IPC: F23R3/28
Filed: 2006-11-02
Granted: 2014-04-15
Abstract: A method facilitates operating a gas turbine engine (10). The method comprises supplying steam and primary fuel to a chamber (160) within a nozzle (50), mixing the primary fuel and steam within the chamber, and discharging the mixture into a combustor (16) from a plurality of circumferentially spaced mixture outlets (104).
Patent CA-2567022-C (CA)
Title: Method of promoting unrestricted flow of irrigation water through irrigation networks
Inventor: IVERSON CARL E
IPC: C02F1/68
Filed: 2006-11-01
Granted: 2012-02-07
Abstract: A biofilm reducing agent (BRA) and a mineral deposit distorting agent (MDDA) are admixed to irrigation water in amounts sufficient to substantially eliminate biofilm formation in the emitters (14) of an irrigation system (10) and produce amorphous mineral deposits in the emitters that are easily washed away by the irrigation water as it flows through the emitters (14). The BRA may be an oxidizer selected from the group consisting of chlorine, ozone, chlorine dioxide, hydrogen peroxide, hydroxy peracitic acid, iodine, bromine, hydrogen dioxide, chlorate salts, chlorite salts and hypochlorite compound and mixtures thereof. The MDDA is a phosphonate selected from the group comprising AMP, ATMP, HEDP, EDTMPA, HMDTMPA, DETPMPA, BHMPTMPA, PBTC, HPA, PCA, NTMP, and DTPMP.
Patent CA-2567599-C (CA)
Inventor: BROLASKI MARK N
IPC: C12N15/10
Filed: 2005-05-20
Granted: 2015-07-21
Abstract: The invention provides methods and compositions, e.g., kits, for removing contaminants from nucleic acids in a sample, e.g., environmental or biological samples such as soil, food, plant, animal, microorganism or water samples. The invention provides methods and compositions for isolating nucleic acids from environmental and biological samples in a scaleable process free of contaminating substances that inhibit PCR and other downstream applications.  Exemplary sample types include soil, water, plant and food. The methods and compositions of the invention can be used for isolating and/or detecting nucleic acids from prokaryotic and eukaryotic organisms and for detecting multiple types of organisms in a sample. Thus, the methods and compositions of the invention are useful for detecting organisms pertaining to agriculture, forensics biology and/or combating bioterrorism.
Patent CA-2569970-C (CA)
Title: Retardateurs optiques a couche mince
Inventor: HENDRIX KAREN D
IPC: G02F1/13363
Filed: 2006-12-04
Granted: 2015-03-31
Abstract: Un dépôt à angle oblique permet dobtenir un retardateur optique à plaque A comportant au moins une couche biréfringente de forme dense. Selon un mode de réalisation, les couches biréfringentes de forme denses sont déposées comme faisant partie dune chaîne de résonateur acoustique en volume à couche mince pour créer un retardateur de découpage à plaque A/C pleine fonction, tout diélectrique, aux fins de la compensation de biréfringence daffichage à cristaux liquides. La structure dense du retardateur de découpage à plaque A/C pleine fonction présente lavantage doffrir une durabilité et une stabilité élevées, ce qui fait quelle est bien adaptée pour assurer une compensation de polarisation dans des systèmes de projection à base de polarisation de flux de lumière élevé.
Patent CA-2571318-C (CA)
Title: Regeneration de nerfs par transplantation de cellules exprimant une superfamille de facteurs de croissance de transformation de proteines
Inventor: KIM CHANG HWAN
IPC: A61K35/30
Filed: 2005-06-23
Granted: 2011-06-07
Abstract: L'invention concerne un procédé pour régénérer des nerfs comprenant la production d'un vecteur plasmide ou viral recombiné comprenant une séquence ADN codant un élément d'une superfamille de facteurs de croissance de transformation de protéines liées de manière fonctionnelle à un promoteur, transfection in vitro d'une population de cellules mises en culture au moyen du vecteur recombiné, résultant d'une population de cellules mises en culture ; et transplantation des cellules transfectées dans une zone proche du nerf blessé, de sorte que l'expression de la séquence d'ADN à l'intérieur de cette zone entraîne la régénération du nerf.
Patent CA-2573447-C (CA)
Title: Improved surgical cassette
Inventor: HOPKINS MARK A
IPC: A61F9/007
Filed: 2007-01-09
Granted: 2010-06-15
Abstract: A cassette having an elastomeric sheet that is bonded or mechanically attached to a rigid substrate. A flow channel is molded into the rigid substrate that corresponds to a flow channel molded into the elastomeric sheet. The cassette is used in combination with a peristaltic pump having pump head rollers that are mounted radially from the axis of rotation of the pump motor so as to compress the elastomeric flow channels against the rigid substrate during operation. The flow channels molded into the rigid substrate have smooth, fluid lines free from sharp edges and abrupt direction changes and correspond with the fluid channels molded into the elastomeric sheet so as to provide a transition region with a relatively constant cross-section over its entire length that approximates the cross- sectional area of the flow channels molded into the rigid substrate and the fluid channel molded into the elastomeric sheet so that the entire fluid path is of relatively constant cross-sectional area.
Patent CA-2577073-C (CA)
Inventor: GAO YIJIE
IPC: C12N15/63
Filed: 2005-09-01
Granted: 2016-10-11
Abstract: La présente invention concerne des systèmes et des procédés permettant de produire des protéines présentant un intérêt. Les procédés décrits dans cette invention consistent à utiliser des cellules végétales ou animales génétiquement modifiées présentant des capacités de traitement ou de pliage de protéines modifiées. Un aspect de cette invention concerne des cellules génétiquement modifiées comprenant une ou plusieurs cassettes d'expression de recombinaison codant (1) pour une protéine présentant un intérêt, et (2) pour un polypeptide qui est fonctionnel dans la voie de la réponse des protéines dépliées (UPR) des cellules. L'expression conjointe du polypeptide permet d'augmenter significativement le rendement de la protéine présentant un intérêt dans les cellules génétiquement modifiées. Dans un exemple, les cellules génétiquement modifiées sont des cellules animales et le polypeptide co-exprimé est un composant ou un modulateur d'une voie UPR induite par XBP1- ou ATF6.
Patent CA-2578549-C (CA)
Title: Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
Inventor: HALL JOHN L
IPC: A61K31/4375
Filed: 2005-05-19
Granted: 2014-09-02
Abstract: A method and composition for preventing prostate cancer and/or reducing PSA  levels and/or alleviating the symptoms of BPH  (Benign Prostatic Hyperplasia) or PIN (prostatic intraepithelial neoplasia) by administration of an effective amount of a mixture of flavopereirine and alstonine. A method and composition for treating low-grade prostate cancer and preventing the onset of metastatic disease and/or reducing the doubling time of PSA levels in men with positive biopsies showing relatively low Gleason scores and morphologies characteristic of non-invasive, slow-progressing prostate cancer. The flavopereirine and alstonine can be in the form of natural extracts derived from Pao Pereira and Rauwolfia Vomitoria, respectively.  Alternatively, these two active compounds can be administered in purified form. The composition can be in included in a kit along with instructions for use in a treatment regimen.
Patent CA-2584170-C (CA)
Inventor: STAEHLE WOLFGANG
IPC: A61K31/437
Filed: 2005-09-16
Granted: 2013-08-20
Abstract: The invention relates to the compounds of formula (I), (see formula I) wherein R1a-R1e, R2a, R2b, R3 and X are defined as in the specification. The inventive derivatives are tyrosinkinase inhibitors, especially inhibitors of TIE-2, and Raf kinase inhibitors and may inter alia be used for treating tumors.